BioMarin stops mid-stage trials of bone disorder treatment [Yahoo! Finance]
BioMarin Pharmaceutical Inc. (BMRN)
Last biomarin pharmaceutical inc. earnings: 4/29 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investors.biomarin.com
Company Research
Source: Yahoo! Finance
patients' hip joint ?slipping out of place, the drugmaker said on Monday, sending ?its shares down 4%. * BioMarin was testing its drug Voxzogo in patients withTurner Syndrome, SHOX-deficiency and Aggrecan (ACAN)-deficiency,which are distinct genetic conditions that causes severe shortstature and in ?some cases abnormal ?bone development. * Turner syndrome occurs in females missing part or all ofan X chromosome, ?SHOX deficiency results from a missing orfaulty growth-related gene, and ACAN deficiency is caused bymutations in a ?gene important ?for cartilage structure. * During ?the mid-stage trials, several ?patients facedslipped capital femoral epiphysis, where the ball of the hipjoint slips off the thigh bone at the area where the bone isstill growing. * BioMarin said it will continue testing the drug inpatients with Noonan ?syndrome where typical development stops ?invarious parts of the body, ?and in patients ?with a form ofunexplained short stature. * The ?U.S. Food and Drug Adm
Show less
Read more
Impact Snapshot
Event Time:
BMRN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
BMRN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
BMRN alerts
High impacting BioMarin Pharmaceutical Inc. news events
Weekly update
A roundup of the hottest topics
BMRN
News
- Q4 Earnings Highlights: BioMarin Pharmaceutical (NASDAQ:BMRN) Vs The Rest Of The Therapeutics Stocks [Yahoo! Finance]Yahoo! Finance
- How The BioMarin (BMRN) Story Is Shifting With Voxzogo Risks And The Amicus Deal [Yahoo! Finance]Yahoo! Finance
- BioMarin discontinues dosing in certain Voxzogo trials after safety concern [Yahoo! Finance]Yahoo! Finance
- BioMarin Pharmaceutical (BMRN) had its "outperform" rating reaffirmed by Wolfe Research.MarketBeat
- BioMarin Pharmaceutical (BMRN) Receives FDA Approval for Expanded Use of PALYNZIQ in Adolescents [Yahoo! Finance]Yahoo! Finance
BMRN
Earnings
- 2/23/26 - Beat
BMRN
Sec Filings
- 3/19/26 - Form 4
- 3/19/26 - Form 4
- 3/19/26 - Form 4
- BMRN's page on the SEC website